DeepMed I/O Quality Policy

Our mission at DeepMed I/O, to increase the easiness to use, friendliness, accuracy and speed of diagnostic processes and deliver safe, accurate and efficient personalized care solutions for patients, thus minimising the risk of misdiagnosis, incomplete diagnosis, aiming to prolong patients’ survival rate and period as well as improving their quality of life by providing significant information assisting the medics’ precision medical point of view and medical guidance.

DeepMed I/O is committed to design, develop and produce safe and effectiveproducts to applicable specifications that meet national, European and International Standards and Regulatory Requirements.

To meet customers satisfaction without contradicting Standard and Regulatory Requirements.

To meet the highest standards of Regulatory and Quality compliance for our business.

To continuously monitor and track the performance of our Quality Management System via key performance indicators.

To repeatedly improve the Quality Management System.

The Company’s top management considers itself a leader that is involved in all aspects of this policy’s implementation, and through its Quality Representative is solely responsible for the quality of its product, utilizing personal commitment of all its employees.

DeepMed I/O provides the appropriate human and financial resources as well as the necessary equipment to carry out the design, development, production and technical support, in relation to relevant AI based medical product(s) and finally to achieve its core objectives.

DeepMed I/O has developed and implemented a Quality Management System to be fully compliant as per ISO 13485:2016.

DeepMed I/O has applied its quality management system into all aspects of its activities to demonstrate its ability to consistently provide products that meet customer and regulatory requirements, and to address customer satisfaction through the effective application of the system, including continual improvement and the prevention of nonconformity.

Managing Director

Konstantinos Vougas

Athens, 5/10/2021